Limited benefit and high financial burden of drugs used to manage cancer-associated anorexia/cachexia syndrome (CACS).

Arjun Gupta,Leonce Nshuti,Udhayvir Singh Grewal,Ramy Sedhom,Helen Parsons,Anne H. Blaes,Beth A Virnig,Maryam B. Lustberg,Ishwaria Mohan Subbiah,Ryan D. Nipp,Sydney M. Dy,Stacie B. Dusetzina

Limited benefit and high financial burden of drugs used to manage cancer-associated anorexia/cachexia syndrome (CACS).

2021

Arjun Gupta
Leonce Nshuti
Udhayvir Singh Grewal
Ramy Sedhom
Helen Parsons
Anne H. Blaes
Beth A Virnig
Maryam B. Lustberg
Ishwaria Mohan Subbiah
Ryan D. Nipp
Sydney M. Dy
Stacie B. Dusetzina

55Background: To date, drugs used for CACS have limited efficacy and may have unwanted side effects. Despite this, clinicians commonly prescribe certain drugs for CACS, adding financial burden to p...

Keywords:

Cancer
Anorexia
Cachexia
Finance
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations